Thus, strategies aimed at targeting the toxicity of cytoplasmic TDP-43 aggregates may be effective.

We observed cytoplasmic TDP-43 accumulation o in the presence of tau in these cell models.

Mutations in the gene encoding TDP-43 cause some forms of the disease, and cytoplasmic TDP-43 aggregates accumulate in degenerating neurons of most individuals with ALS.